New(ish) Drug for MACE Prevention

Primary Care Pod by Dr. Mark List

Mar 5, 202315:30Health

Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention). NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.

Related Episodes

Continue listening to more episodes from Primary Care Pod.

USPSTF 2024 Breast Cancer Screening Guideline Update!

May 7, 2024 - 16:03

A New Pandemic? PICKLEBALL INJURIES ON THE RISE!

Jul 7, 2023 - 4:58

Fun, quick episode this week. Non-fatal senior pickleball and tennis-related injuries treated in United S...

First Unprovoked VTE, Cause for Lifelong Blood Thinners?

Jul 4, 2023 - 16:25

Today's episode is a very complicated topic without clear cut benefits. Expert opinions and modeling data...

Intermittent Fasting vs. Caloric Restriction, Head to Head!

Jun 28, 2023 - 15:45

Time restricted eating vs. caloric restriction. Is there a winner in this 1:1:1 12-month trial from Chica...

New RSV Vaccine Studies!

May 24, 2023 - 22:58

Talking about 2 studies released last month: 1. Giving it to 3rd trimester moms and seeing what happens i...

Personalization - A New Treatment Algorithm for Blood Pressure Management

Apr 25, 2023 - 13:36

Hey everyone, on today's episode we are talking about a recent JAMA article on Heterogeneity in Blood Pre...

Treating Resistant Depression in Elders - Add or Switch Meds?

Mar 21, 2023 - 16:53

Today's episode we look at a study of 60+ year olds who have poorly controlled depression. Is it better t...

Asthma Management: Less is More?

Mar 5, 2023 - 15:59

Interesting study today that looks at High dose ICS inhalers possibly have worse outcomes in patients tha...